China TCM (570.HK) Update - Despite Doubts, This Privatization Seems “Mandatory”
Some investors have concerns that the privatization may fail, but China TCM's privatization seems "mandatory", which will lead to spin-off...
555 Views
Merger Arb Mondays (06 May) - China TCM, L'Occitane, Hollysys, Shinko, QV Equities, Qantm IP, Adbri
This week, the highest gross spreads are Hollysys (12.1%), QV Equities (11.4%), Southern Cross (9.0%), Qantm IP (8.2%), Probiotec (7.4%), China TCM...
389 Views
China TCM (570.HK) - Latest Updates on Privatization and the Potential Merger with Taiji Group
The privatization is highly likely to succeed. It's not wise for investors to bet against privatization.Taiji's high-level personnel changes...
688 Views
Merger Arb Mondays (26 Feb) - China TCM, Azure, A2B, Boral, CSR, Outsourcing, Snow Peak, Genetron
This week, the highest gross spreads are Probiotec (10.2%), JSR (7.6%), Shinko Electric (7.6%), CSR (7.4%), China TCM (7.2%), Lithium Power (6.5%),...
843 Views
(Mostly) Asia-Pac Weekly Risk Arb Wrap: Boral, CSR, Ansarada, TCM, Snow Peak, Azure Min, Genetron
This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...
396 Views